(NYSE:AGL), NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of agilon health, inc. (“Agilon” or the “Company”) (NYSE: AGL) that a federal securities class action has been filed on behalf of investors who purchased Agilon between February 6, 2025 and August 4, 2025, inclusive […]

Shareholders who lost money in shares of agilon health, inc. (NYSE: AGL) Should Contact Wolf Haldenstein Immediately Lead Plaintiff Deadline is March 2, 2026 GlobeNewswire January 07, 2026 NEW YORK, Jan. 07, 2026 (GLOBE NEWSWIRE) — Wolf Haldenstein Adler Freeman & Herz LLP reminds purchasers or acquirers of agilon health, inc. (“Agilon” or the “Company”)

ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus Conference Call Scheduled for Friday, January 9, 2026 at 9:00 AM ET GlobeNewswire January 07, 2026 PORTLAND, Maine, Jan. 07, 2026 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), an animal health company that develops, manufactures and markets products

BCI and Stanford Researchers Demonstrate ESG Value Creation in Private Equity New research provides evidence of how ESG drives returns in private markets GlobeNewswire January 07, 2026 VICTORIA, B.C. & STANFORD, CALIFORNIA, Jan. 07, 2026 (GLOBE NEWSWIRE) — British Columbia Investment Management Corporation (BCI), one of Canada's largest institutional investors, and Stanford University's Long-Term Investing

New York, New York–(Newsfile Corp. – January 7, 2026) – Broadreach Medical Resources (BMR), a leader in pharmacy benefit consulting and strategic clinical management, announces our rebrand to HarmonyRx-a name that represents the company’s evolution, mission and commitment to aligning clinical excellence with financial value. The new brand identity reflects HarmonyRx’s philosophy: that the most

(NASDAQ:FRSX),(TASE:FRSX.TA), Beyond line-of-sight V2X technology protects vulnerable road users in connected and autonomous mobility Ness Ziona, Israel, Jan. 07, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, today announced that its majority-owned subsidiary, Eye-Net Mobile Ltd. (“Eye-Net”), will participate in CES

Foresight: Eye-Net to Showcase its Innovative V2X Collision Prevention Technology at CES 2026 in Las Vegas GlobeNewswire January 07, 2026 Beyond line-of-sight V2X technology protects vulnerable road users in connected and autonomous mobility Ness Ziona, Israel, Jan. 07, 2026 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an

GALWAY, IRELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) — Luminate, a healthcare technology company which helps patients to receive cancer treatments at home, has raised $21 million in an expanded Series A round, taking its total funding to date to over $50 million. The round was co-led by ARTIS Ventures and Lachy Groom with participation from

Luminate Raises $21 Million in Funding to Expand Home Cancer Treatment ARTIS Ventures, Lachy Groom, and Western Alliance Bank lead funding round in Y Combinator company delivering cancer therapies at home GlobeNewswire January 07, 2026 GALWAY, IRELAND, Jan. 07, 2026 (GLOBE NEWSWIRE) — Luminate, a healthcare technology company which helps patients to receive cancer treatments

TANAKA MIRAI Lab., an in-house innovation organization of TANAKA PRECIOUS METAL GROUP Co., Ltd. (head office: Chuo-ku, Tokyo; Group CEO: Koichiro Tanaka), launched the Precious Fragrance Project in fiscal year 2025 as part of its initiatives in the new "Precious Things" field, where it seeks to create new value. The first fruit of this project